HARVONI (harVOEnee) (ledipasvir and (HARVONI(harVOEnee)(ledipasvir和).pdf

HARVONI (harVOEnee) (ledipasvir and (HARVONI(harVOEnee)(ledipasvir和).pdf

  1. 1、本文档共2页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
HARVONI (harVOEnee) (ledipasvir and (HARVONI(harVOEnee)(ledipasvir和)

Patient Information ® HARVONI (har-VOE-nee) (ledipasvir and sofosbuvir) tablets Important: If you take HARVONI with ribavirin, you should also read the Medication Guide for ribavirin. What is the most important information I should know about HARVONI? HARVONI can cause serious side effects, including, Hepatitis B virus reactivation: Before starting treatment with HARVONI, your healthcare provider will do blood tests to check for hepatitis B virus infection. If you have ever had hepatitis B virus infection, the hepatitis B virus could become active again during or after treatment of hepatitis C virus with HARVONI. Hepatitis B virus becoming active again (called reactivation) may cause serious liver problems including liver failure and death. Your healthcare provider will monitor you if you are at risk for hepatitis B virus reactivation during treatment and after you stop taking HARVONI. For more information about side effects, see the section “What are the possible side effects of HARVONI?” What is HARVONI? HARVONI is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C virus (HCV): • genotype 1, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis • genotype 1 infection with advanced cirrhosis (decompensated) in combination with ribavirin • genotype 1 or 4 infection without cirrhosis or with compensated cirrhosis who have had a liver transplant, in combination with ribavirin HARVONI is used to treat children 12 years of age and older or weighing at least 77 pounds (at least 35 kg) with chronic HCV genotype 1, 4, 5, or 6 without cirrhosis or with compensated cirrhosis. It is not known if HARVONI is safe and effective in children with HCV under 12

文档评论(0)

wnqwwy20 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:7014141164000003

1亿VIP精品文档

相关文档